AIDS

1. CAHN P, Madero JS, Arribas JR, Antinori A, et al
   Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy-naive adults with HIV-1 infection.
   AIDS. 2021 Sep 15. pii: 00002030-900000000-96314.
   

   >> Share

   
   
2. NACCARATO M, Kwee F, Zaltzman J, Fong IW, et al
   Ritonavir-boosted antiretroviral therapy precipitating tacrolimus toxicity in a renal transplant patient: is it time for a priori tacrolimus dosage reduction?
   AIDS. 2021;35:2065-2068.
   

   >> Share

   
   
3. ANDREIA A, Cappello C, Stirrup O
   High-risk hpv, precancerous lesions and cancer in anal condylomas: systematic review and meta-analysis.
   AIDS. 2021 Jun 7. pii: 00002030-900000000-96383.
   

   >> Share

   
   

   
   AIDS Res Hum Retroviruses

4. MCGOWAN IM, Kunjara Na Ayudhya RP, Brand RM, Marzinke MA, et al
   An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine / Tenofovir Disoproxil Fumarate.
   AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2021.0115.
   

   >> Share

   
   
5. BOUCHARD A, Bourdeau F, Roger J, Taillefer VT, et al
   Predictive Factors of Detectable Viral Load in HIV Infected Patients.
   AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2021.0106.
   

   >> Share

   
   
6. MCMANUS KA, Schurman E, An Z, Van Hook R, et al
   Patient Perspective of People with HIV who Gained Medicaid through Medicaid Expansion: A Cross-sectional Qualitative Study.
   AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2021.0129.
   

   >> Share

   
   
7. THET D, Siritientong T, Sangarlangkarn A, Mar Su Lwin H, et al
   Deterioration of nutritional status and its negative association with depression among older HIV-infected Asian population: a four-year longitudinal study.
   AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2021.0087.
   

   >> Share

   
   
8. STIRES H, LaMori J, Chow W, Zalewski Z, et al
   Weight Gain and Related Co-Morbidities Following Antiretroviral Initiation in the 2000s: A Systematic Literature Review.
   AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2020.0216.
   

   >> Share

   
   
9. SARKAR S, Haberlen S, Post WS, Kelesidis T, et al
   Short Communication: Plasma Lymphocyte Activation Gene 3 and Subclinical Coronary Artery Disease in the Multicenter AIDS Cohort Study.
   AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/aid.2021.0035.
   

   >> Share

   
   
10. GUTHRIE KM, Rosen RK, Guillen M, Ramirez JJ, et al
    Designing dual compartment HIV prevention products: Women's sensory perceptions and experiences of suppositories for rectal and vaginal use.
    AIDS Res Hum Retroviruses. 2021 Sep 21. doi: 10.1089/AID.2021.0038.
    

    >> Share

    
    
11. ALVES CGB, Assis MS, Maciel ADS, da Silva JC, et al
    Clinical and laboratory profile of people living with HIV/AIDS with oral Kaposi sarcoma.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2020.0311.
    

    >> Share

    
    

    
    Ann Intern Med

12. LINAS BP
    Ending HIV in the United States Will Require a Substantial Financial Commitment.
    Ann Intern Med. 2021 Sep 21. doi: 10.7326/M21-3607.
    

    >> Share

    
    
13. FOJO AT, Schnure M, Kasaie P, Dowdy DW, et al
    What Will It Take to End HIV in the United States? : A Comprehensive, Local-Level Modeling Study.
    Ann Intern Med. 2021 Sep 21. doi: 10.7326/M21-1501.
    

    >> Share

    
    

    
    Antimicrob Agents Chemother

14. ABDELWAHAB MT, Wasserman S, Brust JCM, Dheda K, et al
    Linezolid population pharmacokinetics in South African adults with drug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2021 Sep 20:AAC0138121. doi: 10.1128/AAC.01381.
    

    >> Share

    
    

    
    BMJ

15. HIPPISLEY-COX J, Coupland CA, Mehta N, Keogh RH, et al
    Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.
    BMJ. 2021;374:n2244.
    

    >> Share

    
    

    
    Clin Infect Dis

16. OH CE, Ortiz-Brizuela E, Bastos ML, Menzies D, et al
    Comparing the Diagnostic Performance of QFT-Plus to Other Tests of Latent Tuberculosis Infection: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2020 Dec 8. pii: 6026460. doi: 10.1093/cid/ciaa1822.
    

    >> Share

    
    
17. FWOLOSHI S, Hines JZ, Barradas DT, Yingst S, et al
    Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) among Health Care Workers-Zambia, July 2020.
    Clin Infect Dis. 2021 Mar 30. pii: 6204763. doi: 10.1093.
    

    >> Share

    
    
18. BURKE RM, Gupta Wright A
    Diagnosing Tuberculosis in People With Advanced Human Immunodeficiency Virus: More Is Needed.
    Clin Infect Dis. 2021;73:e878-e879.
    

    >> Share

    
    
19. TIRABOSCHI J, Scevola S, Dilly Penchala S, Challenger E, et al
    Doravirine Achieves Adequate CSF Exposure and is Mostly Unbound to Proteins.
    Clin Infect Dis. 2021 Sep 21. pii: 6373514. doi: 10.1093.
    

    >> Share

    
    
20. SUTHERLAND JS, van der Spuy G, Gindeh A, Thuong NT, et al
    Diagnostic accuracy of the Cepheid 3-gene host response fingerstick blood test in a prospective, multi-site study: interim results.
    Clin Infect Dis. 2021 Sep 22. pii: 6373967. doi: 10.1093.
    

    >> Share

    
    
21. FORD N, Vitoria M, Doherty M
    WHO guidance to support HIV care models during the Covid-19 era.
    Clin Infect Dis. 2021 Sep 24. pii: 6374892. doi: 10.1093.
    

    >> Share

    
    

    
    HIV Med

22. BROWN AE, Croxford SE, Nash S, Khawam J, et al
    COVID-19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID-19 pandemic in England.
    HIV Med. 2021 Sep 15. doi: 10.1111/hiv.13167.
    

    >> Share

    
    
23. MAZZITELLI M, Branca Isabel P, Muramatsu T, Chirwa M, et al
    FRAX assessment in people ageing with HIV.
    HIV Med. 2021 Sep 19. doi: 10.1111/hiv.13170.
    

    >> Share

    
    
24. LEE MJ, Snell LB, Douthwaite ST, Fidler S, et al
    Clinical outcomes of patients with and without HIV hospitalized with COVID-19 in England during the early stages of the pandemic: a matched retrospective multi-centre analysis (RECEDE-C19 study).
    HIV Med. 2021 Sep 23. doi: 10.1111/hiv.13174.
    

    >> Share

    
    
25. BURKE RM, Rickman HM, Singh V, Kalua T, et al
    Same-day antiretroviral therapy initiation for people living with HIV who have tuberculosis symptoms: a systematic review.
    HIV Med. 2021 Sep 15. doi: 10.1111/hiv.13169.
    

    >> Share

    
    

    
    J Acquir Immune Defic Syndr

26. RAJU S, Astemborski J, Drummond MB, Ramamurthi HC, et al
    HIV is Associated with Impaired Pulmonary Diffusing Capacity Independent of Emphysema.
    J Acquir Immune Defic Syndr. 2021 Sep 24. pii: 00126334-900000000-95797.
    

    >> Share

    
    
27. AUNG S, Hardy N, Chrysanthopoulou SA, Kyaw A, et al
    Stigma Determines Antiretroviral Adherence in Adults with HIV in Myanmar.
    J Acquir Immune Defic Syndr. 2021 Sep 17. pii: 00126334-900000000-95804.
    

    >> Share

    
    
28. CHAS J, Bauer R, Larabi IA, Peytavin G, et al
    Evaluation of Drug Abuse by Hair Analysis and Self-Reported Use Among MSM Under PrEP: Results From a French Substudy of the ANRS-IPERGAY Trial.
    J Acquir Immune Defic Syndr. 2021;86:552-561.
    

    >> Share

    
    

    
    J Infect Dis

29. WARD KM, Falade-Nwulia O, Moon J, Sutcliffe CG, et al
    Non-adherence to LDV/SOF did not predict SVR in a randomized controlled trial of HIV/HCV coinfected persons who use drugs.
    J Infect Dis. 2021 Sep 20. pii: 6372878. doi: 10.1093.
    

    >> Share

    
    

    
    J Virol

30. SMITH LM, Ladner JT, Hodara VL, Parodi LM, et al
    MULTIPLEXED SIV-SPECIFIC PAIRED RNA-GUIDED CAS9 NICKASES INACTIVATE PROVIRAL DNA.
    J Virol. 2021 Sep 22:JVI0088221. doi: 10.1128/JVI.00882.
    

    >> Share

    
    
31. ZHANG S, Wang K, Wang WL, Nguyen HT, et al
    Asymmetric structures and conformational plasticity of the uncleaved full-length human immunodeficiency virus (HIV-1) envelope glycoprotein trimer.
    J Virol. 2021 Sep 22:JVI0052921. doi: 10.1128/JVI.00529.
    

    >> Share

    
    
32. LAI M, Maori E, Quaranta P, Matteoli G, et al
    CRISPR/Cas9 ablation of integrated HIV-1 accumulates proviral DNA circles with reformed LTRs.
    J Virol. 2021 Sep 22:JVI0135821. doi: 10.1128/JVI.01358.
    

    >> Share

    
    

    
    Lancet

33. KRAUSE PR, Fleming TR, Peto R, Longini IM, et al
    Considerations in boosting COVID-19 vaccine immune responses.
    Lancet. 2021 Sep 14. pii: S0140-6736(21)02046.
    

    >> Share

    
    
34. ZUNIGA JM, Russell A, Lusimbo R, Tshabalala S, et al
    The costs of PEPFAR's leadership vacuum.
    Lancet. 2021;398:741.
    

    >> Share

    
    

    
    Lancet Infect Dis

35. KIANG MV, Chin ET, Huynh BQ, Chapman LAC, et al
    Addendum needed on COVID-19 travel study - Authors' reply.
    Lancet Infect Dis. 2021 Sep 15. pii: S1473-3099(21)00562.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

36. HECHT J, Sanchez T, Sullivan PS, DiNenno EA, et al
    Increasing Access to HIV Testing Through Direct-to-Consumer HIV Self-Test Distribution - United States, March 31, 2020-March 30, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1322-1325.
    

    >> Share

    
    

    
    Nature

37. SCHMIDT F, Weisblum Y, Rutkowska M, Poston D, et al
    High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape.
    Nature. 2021 Sep 20. pii: 10.1038/s41586-021-04005.
    

    >> Share

    
    

    
    PLoS Comput Biol

38. MAZROUEE S, Little SJ, Wertheim JO
    Incorporating metadata in HIV transmission network reconstruction: A machine learning feasibility assessment.
    PLoS Comput Biol. 2021;17:e1009336.
    

    >> Share

    
    

    
    PLoS Med

39. FORD N, Eshun-Wilson I, Ameyan W, Newman M, et al
    Future directions for HIV service delivery research: Research gaps identified through WHO guideline development process.
    PLoS Med. 2021;18:e1003812.
    

    >> Share

    
    
40. HICKEY MD, Ayieko J, Owaraganise A, Sim N, et al
    Effect of a patient-centered hypertension delivery strategy on all-cause mortality: Secondary analysis of SEARCH, a community-randomized trial in rural Kenya and Uganda.
    PLoS Med. 2021;18:e1003803.
    

    >> Share

    
    
41. HERCE ME, Chagomerana MB, Zalla LC, Carbone NB, et al
    Community-facility linkage models and maternal and infant health outcomes in Malawi's PMTCT/ART program: A cohort study.
    PLoS Med. 2021;18:e1003780.
    

    >> Share

    
    

    
    PLoS One

42. NARH-BANA SA, Kawonga M, Chirwa ED, Ibisomi L, et al
    Fidelity of implementation of TB screening guidelines by health providers at selected HIV clinics in Ghana.
    PLoS One. 2021;16:e0257486.
    

    >> Share

    
    
43. MARTIN EG, Ansari B, Hart-Malloy R, Smith DK, et al
    Racial and ethnic disparities in HIV diagnoses among heterosexually active persons in the United States nationally and by state, 2018.
    PLoS One. 2021;16:e0257583.
    

    >> Share

    
    
44. JAHUN I, Said I, El-Imam I, Ehoche A, et al
    Optimizing community linkage to care and antiretroviral therapy Initiation: Lessons from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) and their adaptation in Nigeria ART Surge.
    PLoS One. 2021;16:e0257476.
    

    >> Share

    
    
45. MARQUEZ C, Kerkhoff AD, Naso J, Contreras MG, et al
    A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: From theory to practice.
    PLoS One. 2021;16:e0257111.
    

    >> Share

    
    
46. BISETEGN H, Ebrahim H
    The prevalence of thrombocytopenia and leucopenia among people living with HIV/AIDS in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0257630.
    

    >> Share

    
    
47. PANRAKSA Y, Amin AG, Graham B, Henry CS, et al
    Immobilization of Proteinase K for urine pretreatment to improve diagnostic accuracy of active tuberculosis.
    PLoS One. 2021;16:e0257615.
    

    >> Share

    
    
48. JOHN L, Odero N, Nziku J, Njau B, et al
    Gap analysis between expectations and perceptions of pregnant women attending Prevention of Maternal to Child Transmission of HIV services in a private referral hospital in northern Tanzania: A cross-sectional descriptive study.
    PLoS One. 2021;16:e0257771.
    

    >> Share

    
    
49. O'BRIEN KK, Davis AM, Chan Carusone S, Avery L, et al
    Examining the impact of a community-based exercise intervention on cardiorespiratory fitness, cardiovascular health, strength, flexibility and physical activity among adults living with HIV: A three-phased intervention study.
    PLoS One. 2021;16:e0257639.
    

    >> Share

    
    
50. IRUNGU BN, Koech LC, Ondicho JM, Keter LK, et al
    Quality assessment of selected co-trimoxazole suspension brands marketed in Nairobi County, Kenya.
    PLoS One. 2021;16:e0257625.
    

    >> Share

    
    
51. GUURE C, Dery S, Afagbedzi S, Tun W, et al
    National and subnational size estimation of female sex workers in Ghana 2020: Comparing 3-source capture-recapture with other approaches.
    PLoS One. 2021;16:e0256949.
    

    >> Share

    
    

    
    PLoS Pathog

52. ALJEDANI SS, Liban TJ, Tran K, Phad G, et al
    Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.
    PLoS Pathog. 2021;17:e1009543.
    

    >> Share

    
    
53. LUSTIG G, Cele S, Karim F, Derache A, et al
    T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy.
    PLoS Pathog. 2021;17:e1009871.
    

    >> Share

    
    
54. GUEDAN A, Donaldson CD, Caroe ER, Cosnefroy O, et al
    HIV-1 requires capsid remodelling at the nuclear pore for nuclear entry and integration.
    PLoS Pathog. 2021;17:e1009484.
    

    >> Share

    
    
55. MBONYE U, Leskov K, Shukla M, Valadkhan S, et al
    Biogenesis of P-TEFb in CD4+ T cells to reverse HIV latency is mediated by protein kinase C (PKC)-independent signaling pathways.
    PLoS Pathog. 2021;17:e1009581.
    

    >> Share

    
    
56. MISHRA N, Kumar S, Singh S, Bansal T, et al
    Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma.
    PLoS Pathog. 2021;17:e1009958.
    

    >> Share

    
    

    
    Vaccine

57. ANGSUWATCHARAKON P, Puthanakit T, Bunjoungmanee P, Anugulruengkitt S, et al
    High seroprevalence of rubella in Thai children with a 2-dose MMR national immunization policy.
    Vaccine. 2021 Sep 20. pii: S0264-410X(21)01127.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share